7
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Linearization of Drug Delivery from Sustained-Release Dosage Forms, Synthetic Gel Systems

, &
Pages 431-437 | Published online: 20 Oct 2008
 

Abstract

A linear, apparent zero-order, in vitro release profile may be approximated from triple-pressed tablets using synthetic gum systems in the first and second press coats. This is coupled with varying concentrations of the actives (Melperone HCl. Diethylpropion HCl, and Dyphylline) in the core and press coats. The approximately linear release function obtained from these tablet systems is in stark contrast to a supposedly prolonged release tablet (comparative formulation) from the literature, which actually releases by the square root of time function characteristic of diffusion control. Addition of a placebo press coat to the outside of the synthetic gum systems simply increases the lag times for release (while the placebo coat is undergoing hydration, etc.). The linearity following the lag is reminiscent of saturation kinetics. Results suggest that the almost linear release profile is a function of the concentration of the various layers (core first and second press coats) coupled with the gelation characteristics of the synthetic gums. This zero order release does not hold for the systems of the comparative formulation taken from the patent literature.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.